Skip to content
value.today

Sequent Medical, Inc.

Total raised
$65 M
5 rounds on record
Latest round
$20 M
Mar 2014
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sequent Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2014$20 MNo. 5$10 to $50 million

Sequent Medical, Inc.: Raise no. 5, Mar 2014

Investors in this round

20 investors had bought by the notice of Nov 14, 2014: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kevin J. Cousins · Executive Officer
  • Robert F. Rosenbluth · Executive Officer, Director
  • Thomas C. Wilder, III · Executive Officer, Director
  • Brian J. Cox · Director
  • Donald B. Milder · Director
  • James J. Bochnowski · Director
  • Jonathan B. Root · Director
  • Kirk G Nielsen · Director
  • Nimesh F. Shah · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin J. Cousins, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 14, 2014. Read the notice at the SEC.

equitySEC
Mar 2012$26 MNo. 4$10 to $50 million

Sequent Medical, Inc.: Raise no. 4, Mar 2012

Investors in this round

24 investors had bought by the notice of Mar 19, 2012: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $26 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert F. Rosenbluth · Executive Officer, Director
  • Thomas C. Wilder, III · Executive Officer, Director
  • Brian J. Cox · Director
  • Donald B. Milder · Director
  • Jonathan B. Root · Director
  • Kirk G Nielsen · Director
  • Nimesh F. Shah · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas C. Wilder, III, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 19, 2012. Read the notice at the SEC.

equitySEC
May 2010$16 MNo. 3$10 to $50 million

Sequent Medical, Inc.: Raise no. 3, May 2010

Investors in this round

10 investors had bought by the notice of May 12, 2010: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert F. Rosenbluth · Executive Officer, Director
  • Thomas C. Wilder · Executive Officer, Director
  • Brian J. Cox · Director
  • Donald B. Milder · Director
  • Jonathan B. Root · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas C. Wilder, III, Chief Executive Officer. Source: SEC Form D, newest notice filed May 12, 2010. Read the notice at the SEC.

equitySEC
Mar 2010$1 MNo. 2Under $2 million

Sequent Medical, Inc.: Raise no. 2, Mar 2010

Investors in this round

3 investors had bought by the notice of Mar 18, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert F. Rosenbluth · Executive Officer, Director
  • Thomas C Wilder · Executive Officer, Director
  • Brian J. Cox · Director
  • Donald B. Milder · Director
  • Jonathan B. Root · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas C. Wilder, III, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 18, 2010. Read the notice at the SEC.

debt, optionsSEC
May 2009$3 MNo. 1$2 to $10 million

Sequent Medical, Inc.: Raise no. 1, May 2009

Investors in this round

14 investors had bought by the notice of May 12, 2009: 11 accredited, 3 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • Robert F. Rosenbluth · Executive Officer, Director
  • Brian J. Cox · Director
  • Donald B. Milder · Director
  • Jonathan Root · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian J. Cox, Secretary. Source: SEC Form D, newest notice filed May 12, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sequent Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2014).

    SEC Form D · Nov 2014

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Nov 2014

That is all the official record says: Sequent Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sequent Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 24 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sequent Medical, Inc.
NameRoleNamed in
Kevin J. CousinsExecutive officerNov 2014
Robert F. RosenbluthExecutive officerNov 2014
Thomas C. Wilder, IIIExecutive officerNov 2014
Thomas C. WilderExecutive officerMay 2010
Thomas C WilderExecutive officerMar 2010
Brian J. CoxDirectorNov 2014
Donald B. MilderDirectorNov 2014
James J. BochnowskiDirectorNov 2014
Jonathan B. RootDirectorNov 2014
Kirk G NielsenDirectorNov 2014
Nimesh F. ShahDirectorNov 2014
Robert F. RosenbluthDirectorNov 2014
Thomas C. Wilder, IIIDirectorNov 2014
Thomas C. WilderDirectorMay 2010
Thomas C WilderDirectorMar 2010
Jonathan RootDirectorMay 2009